[up] Up a level
Group by: Item Type | No Grouping
Jump to: Article
Number of items: 6.

Article

Meijboom, KE, Sutton, ER, McCallion, E, McFall, E, Anthony, D, Edwards, B, Kubinski, S, Tapken, I, Bünermann, I, Hazell, G, Ahlskog, N, Claus, P, Davies, KE, Kothary, R, Wood, MJA and Bowerman, M ORCID: https://orcid.org/0000-0002-3579-6403 (2022) Dysregulation of Tweak and Fn14 in skeletal muscle of spinal muscular atrophy mice. Skeletal Muscle, 12 (18). pp. 1-25.

Betts, CA, Jagannath, A, van Westering, TLE, Bowerman, M ORCID: https://orcid.org/0000-0002-3579-6403, Banerjee, S, Meng, J, Falzarano, MS, Cravo, L, McClorey, G, Meijboom, KE, Bhomra, A, Lim, WF, Rinaldi, C, Counsell, JR, Chwalenia, K, O’Donovan, E, Saleh, AF, Gait, MJ, Morgan, JE, Ferlini, A, Foster, RG and Wood, MJA (2021) Dystrophin involvement in peripheral circadian SRF signalling. Life Science Alliance, 4 (10). e202101014 - e202101014.

Meijboom, KE, Volpato, V, Monzón-Sandoval, J, Hoolachan, JM, Hammond, SM, Abendroth, F, de Jong, OG, Hazell, G, Ahlskog, N, Wood, MJA, Webber, C and Bowerman, M ORCID: https://orcid.org/0000-0002-3579-6403 (2021) Combining multi-omics and drug perturbation profiles to identify muscle-specific treatments for spinal muscular atrophy. JCI Insight, 6 (13). pp. 1-24.

Walter, LM, Koch, CE, Betts, CA, Ahlskog, N, Meijboom, KE, van Westering, TLE, Hazell, G, Bhomra, A, Claus, P, Oster, H, Wood, MJA and Bowerman, M ORCID: https://orcid.org/0000-0002-3579-6403 (2018) Light modulation ameliorates expression of circadian genes and disease progression in spinal muscular atrophy mice. Human Molecular Genetics, 27 (20). pp. 3582-3597.

Bowerman, M, Walter, LM, Deguise, M-O, Meijboom, KE, Betts, CA, Ahlskog, N, van Westering, TLE, Hazell, G, McFall, E, Kordala, A, Hammond, SM, Abendroth, F, Murray, LM, Shorrock, HK, Prosdocimo, DA, Haldar, SM, Jain, MK, Gillingwater, TH, Claus, P, Kothary, R and Wood, MJA (2018) Interventions Targeting Glucocorticoid-Krüppel-like Factor 15-Branched-Chain Amino Acid Signaling Improve Disease Phenotypes in Spinal Muscular Atrophy Mice. EBioMedicine, 31. pp. 226-242.

Hammond, SM, Hazell, G, Shabanpoor, F, Saleh, AF, Bowerman, M, Sleigh, JN, Meijboom, KE, Zhou, H, Muntoni, F, Talbot, K, Gait, MJ and Wood, MJA (2016) Systemic peptide-mediated oligonucleotide therapy improves long-term survival in spinal muscular atrophy. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 113 (39). 10962 - 10967.

This list was generated on Tue Oct 31 12:46:37 2023 UTC.